IRIS
ABBADESSA, GIANMARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.760
AS - Asia 1.554
NA - Nord America 1.000
SA - Sud America 296
AF - Africa 28
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.641
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.976
US - Stati Uniti d'America 968
SG - Singapore 529
CN - Cina 414
IE - Irlanda 271
BR - Brasile 239
HK - Hong Kong 237
IT - Italia 172
DE - Germania 121
KR - Corea 105
VN - Vietnam 104
GB - Regno Unito 75
IN - India 67
JP - Giappone 39
AR - Argentina 25
FI - Finlandia 23
UA - Ucraina 18
SE - Svezia 17
AT - Austria 14
MX - Messico 13
CA - Canada 12
EC - Ecuador 12
GR - Grecia 12
FR - Francia 10
MA - Marocco 10
NL - Olanda 10
CZ - Repubblica Ceca 9
ID - Indonesia 9
BE - Belgio 8
IQ - Iraq 7
IL - Israele 6
PL - Polonia 6
TR - Turchia 6
VE - Venezuela 6
CO - Colombia 5
EG - Egitto 5
PK - Pakistan 5
BD - Bangladesh 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
ES - Italia 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
ZA - Sudafrica 3
BH - Bahrain 2
ET - Etiopia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
PA - Panama 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 6.641
Salva come PNG Salva come JPEG
Città #
Moscow 1.061
Dublin 271
Hong Kong 237
Santa Clara 209
Singapore 205
Hefei 134
Dallas 110
Seoul 101
Chandler 70
Munich 57
Bengaluru 49
Beijing 46
Ashburn 44
Ho Chi Minh City 41
Roxbury 34
Princeton 33
Naples 29
New York 29
Cambridge 26
The Dalles 25
São Paulo 22
Los Angeles 20
Bremen 19
Hanoi 19
Jacksonville 19
Caserta 15
Medford 14
Ann Arbor 13
Boardman 12
Helsinki 11
Milan 11
Falkenstein 9
Brussels 8
Des Moines 8
Rio de Janeiro 8
Stockholm 8
Brasília 7
Chicago 6
Grafing 6
Guangzhou 6
Lappeenranta 6
Mexico City 6
Pasadena 6
Rome 6
San Francisco 6
Tokyo 6
Turku 6
Boston 5
Brno 5
Curitiba 5
Nuremberg 5
Phoenix 5
Porto Alegre 5
Redwood City 5
Vienna 5
Viterbo 5
Wilmington 5
Amsterdam 4
Atlanta 4
Brooklyn 4
Buenos Aires 4
Changsha 4
Frankfurt am Main 4
Guarulhos 4
Houston 4
Nanjing 4
Norwalk 4
Rockville 4
Tashkent 4
Toronto 4
Warsaw 4
Ankara 3
Aversa 3
Baghdad 3
Bari 3
Can Tho 3
Casablanca 3
Chennai 3
Columbus 3
Da Nang 3
Darmstadt 3
Guayaquil 3
Haiphong 3
Hyderabad 3
Hải Dương 3
Jinan 3
London 3
Lviv 3
Lấp Vò 3
Marília 3
Meknes 3
Nairobi 3
Newark 3
Ninh Bình 3
Norwich 3
Pune 3
Raleigh 3
São José dos Pinhais 3
Taizhou 3
Tianjin 3
Totale 3.287
Salva come PNG Salva come JPEG
Nome #
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 163
Telemedicine application to headache: a critical review 149
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 147
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 132
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 131
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 127
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 125
e-Health and multiple sclerosis: An update 125
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 125
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 124
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 122
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 120
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 119
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 119
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 118
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 117
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 117
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 116
Disability assessment using Google Maps 115
Social Media and Multiple Sclerosis in the Posttruth Age. 109
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 107
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 107
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 106
Signs and symptoms of COVID-19 in patients with multiple sclerosis 106
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 106
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 103
Digital work engagement among Italian neurologists 103
Readability Analysis of Online Headache and Migraine Information 101
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 100
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 99
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 98
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 97
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 97
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 96
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 96
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 96
Pain, quality of life, and religiosity in people with multiple sclerosis 95
Digital therapeutics in neurology 95
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 94
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 94
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 93
How to manage with telemedicine people with neuromuscular diseases? 92
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 91
The Use of Social Media and Digital Devices Among Italian Neurologists 91
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 90
Public engagement and neurology: An update 90
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 88
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest 87
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 84
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 84
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 84
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study 80
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 79
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 78
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis 76
Emotional facial palsy: an unusual and rarely explored neurological sign 76
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? 73
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 70
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 70
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 69
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 65
Reply to Wostyn, P. Targeting the Cerebrospinal Fluid Compartment in Glaucoma: Still the Dark Side of the Moon? Comment on “Passaro et al. Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? J. Clin. Med. 2023, 12, 6900” 64
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies 62
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 61
Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression 60
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 60
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 58
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 55
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 54
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis 50
Totale 6.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 1 11 2 1 4 12 9
2021/2022240 2 15 4 5 60 15 2 3 17 6 23 88
2022/2023416 63 12 9 11 35 18 2 11 222 6 11 16
2023/2024297 16 11 22 13 79 39 13 5 7 4 11 77
2024/20251.150 2 12 10 75 180 114 145 98 198 98 128 90
2025/20264.477 220 382 387 228 486 2.774 0 0 0 0 0 0
Totale 6.750